eureKARE
Overview
eureKARE is an investment firm that finances and builds companies in the fields of synthetic biology and the microbiome across Europe.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Biomemory | Nov 2022 | Seed | Lead |
| DNA Script | Jan 2022 | Series C | Lead |
| Coave Therapeutics | Jul 2021 | Series B | Co-investor |
| Stellate Therapeutics Inc. | May 2021 | VC Round | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is eureKARE based?
eureKARE is headquartered in Luxembourg.
When was eureKARE founded?
eureKARE was founded in 2020.
How many portfolio companies does eureKARE have?
eureKARE has 4 portfolio companies in Caplight's dataset.
What are some companies in eureKARE's portfolio?
Portfolio companies visible on Caplight include Biomemory, DNA Script, Coave Therapeutics, Stellate Therapeutics Inc..
What was eureKARE's most recent investment shown here?
eureKARE's most recent investment in this portfolio sample was in Biomemory in 2022.
What sectors does eureKARE focus on?
eureKARE focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does eureKARE focus on?
eureKARE typically invests at the Mid stage.
What is eureKARE's AUM?
eureKARE's assets under management are estimated between $60.0M and $60.0M.